We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Predictive Monitoring Safeguards Chronically Ill Patients

By HospiMedica International staff writers
Posted on 09 Sep 2014
Affordable, remote vital-signs monitoring system uses a sophisticated predictive algorithm for cardiac Interpretations on the fly.

The OSTAR A300 remote telehealth vital signs patient monitoring system provides comprehensive, cloud-based monitoring powered by a predictive, three simultaneous interpretations (3SI) algorithm of BP readings to determine cardiac arrhythmia, valve function disease, and coronary artery disease (CAD). More...
The system can be configured based on provider, physician, nurse, chronic disease, drug, and various other accountable care organizations (ACO) metrics, all by using a simple integrated bar code scanner.

Furthermore, the device automatically connects to Wi-Fi and cellphone networks to seamlessly send relevant data, such as BP, interpretive cardiac alerts, pulse oximetry, weight, and pulse rate in real time to an electronic medical record (EMR) and to hospital information exchanges (HIEs) anywhere in the world. The OSTAR A300 remote telehealth vital signs patient monitoring system is a product of OSTAR Healthcare Technology (Vancouver, WA, USA).

“Given the current transformation of healthcare and trend to remote telehealth in the United States, this comprehensive nurse-centered form of remote telehealth changes the game for providers and insurance companies,” commented Paul Markham, MD, President of V3 Healthcare Strategies, a provider of healthcare consulting services. “The concept has the potential to impact shared saving plans in ACOs, while also positively impacting health insurance indicators. The result is reduced cost to healthcare systems and ultimately, to the American healthcare consumer.”

Related Links:

OSTAR Healthcare Technology



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.